Literature DB >> 11289769

Source and route of methicillin-resistant Staphylococcus epidermidis transmitted to the surgical wound during cardio-thoracic surgery. Possibility of preventing wound contamination by use of special scrub suits.

A Tammelin1, A Hambraeus, E Ståhle.   

Abstract

The objective of this study was to trace the source and route of transmission of methicillin-resistant Staphylococcus epidermidis (MRSE) in the surgical wound during cardio-thoracic surgery, and to investigate the possibility of reducing wound contamination by wearing special scrub suits. In total 65 elective operations for coronary artery bypass grafting (CABG) with or without concomitant valve replacement were investigated. All staff present in the operating room wore conventional scrub suits during 33 operations and special scrub suits during 32 operations. Samples were taken from the hands of the scrubbed team after surgical scrub but before putting on sterile gowns and gloves, and from patients' skin (incisional area of sternum and vein harvesting area of legs) after preoperative skin preparation with chlorhexidine gluconate. Air samples were taken during operations. Samples were also taken from the wound just before closure. Total counts of bacteria on sternal skin and from the wound (cfu/cm2) were calculated as well as total counts of bacteria in the air (cfu/m3). Strains of MRSE recovered from the different sampling sites were compared by pulsed field gel electrophoresis (PFGE). It was found that wearing special scrub suits did not reduce the number of air-samples where MRSE was found compared with conventional scrub suits. The risk factor most strongly associated with MRSE in the wound at the end of the operation was preoperative carriage of MRSE on sternal skin; RR 2.42 [95% CI 1.43-4.10], P= 0.021. By use of PFGE, it was possible to identify the probable source for four MRSE isolates recovered from the wound. In three cases the source was the patients own skin. Finding MRSE in air-samples, or on the hands of the scrubbed team, were not risk factors for the recovery of MRSE in the wound at the end of operation. In conclusion, with a total bacterial air count around 20 cfu/m3 and a low proportion of MRSE, the reduction of total air counts by use of tightly woven special scrub suits did not reduce air counts of MRSE or wound contamination with MRSE. The patients' sternal skin was the main source for wound contamination with MRSE Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2001        PMID: 11289769     DOI: 10.1053/jhin.2000.0914

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Antimicrobial efficacy of preoperative skin antisepsis and clonal relationship to postantiseptic skin-and-wound flora in patients undergoing clean orthopedic surgery.

Authors:  G Daeschlein; M Napp; F Layer; S von Podewils; H Haase; R Spitzmueller; O Assadian; R Kasch; G Werner; M Jünger; P Hinz; A Ekkernkamp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-04       Impact factor: 3.267

Review 2.  Surgical site infections--economic consequences for the health care system.

Authors:  Karolin Graf; Ella Ott; Ralf-Peter Vonberg; Christian Kuehn; Tobias Schilling; Axel Haverich; Iris Freya Chaberny
Journal:  Langenbecks Arch Surg       Date:  2011-03-15       Impact factor: 3.445

3.  Reply to Hambraeus and Lytsy.

Authors:  Matthew Bartek; Francys Verdial; E Patchen Dellinger
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

4.  Mediastinitis after cardiac surgery: improvement of bacteriological diagnosis by use of multiple tissue samples and strain typing.

Authors:  Ann Tammelin; Anna Hambraeus; Elisabeth Ståhle
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

5.  Attitudes, risk of infection and behaviours in the operating room (the ARIBO Project): a prospective, cross-sectional study.

Authors:  Gabriel Birgand; Christine Azevedo; Gaelle Toupet; Roger Pissard-Gibollet; Bruno Grandbastien; Eric Fleury; Jean-Christophe Lucet
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.